Business Wire- ALung Technologies, Inc., the leading provider of low-flow extracorporeal carbon dioxide removal (ECCO2R) technologies for treating patients with acute respiratory failure, announced today the closing of a $36 million Series C financing, including existing convertible notes.
Recent Posts
Meet the Executive: Tal Heppenstall, President of UPMC Enterprises
It’s been five years since UPMC rebranded its long-standing work on health care innovation and …
Read More →
Get to know FLIGHT
FLIGHT hopes to create opportunities for professional development and mentorship, cultivate the growth of talented women, and increase engagement of women within the organization.
Read More →
Meet the Executive: Sara Fest, Senior Director of Marketing and Communications
Sara Fest got her first taste of communications work in high school where she picked up photography and was an editor of the school newspaper.
Read More →